<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Cooley N</submitter><funding>NHLBI NIH HHS</funding><pagination>318-25</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4028972</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>6(2)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>We investigated the contribution of inositol(1,4,5)-trisphosphate (Ins(1,4,5)P3 [IP3]) receptors (IP3-R) to disease progression in mouse models of dilated cardiomyopathy (DCM) and pressure overload hypertrophy. Mice expressing mammalian sterile 20-like kinase and dominant-negative phosphatidylinositol-3-kinase in heart (Mst1×dn-PI3K-2Tg; DCM-2Tg) develop severe DCM and conduction block, associated with increased expression of type 2 IP3-R (IP3-R(2)) and heightened generation of Ins(1,4,5)P3. Similar increases in Ins(1,4,5)P3 and IP3-R(2) are caused by transverse aortic constriction.&lt;h4>Methods and results&lt;/h4>To evaluate the contribution of IP3-R(2) to disease progression, the DCM-2Tg mice were further crossed with mice in which the type 2 IP3-R (IP3-R(2)-/-) had been de</pubmed_abstract><journal>Circulation. Heart failure</journal><pubmed_title>No contribution of IP3-R(2) to disease phenotype in models of dilated cardiomyopathy or pressure overload hypertrophy.</pubmed_title><pmcid>PMC4028972</pmcid><funding_grant_id>P01 HL080101</funding_grant_id><funding_grant_id>T32 HL007444</funding_grant_id><funding_grant_id>R01 HL095780</funding_grant_id><pubmed_authors>Sheikh F</pubmed_authors><pubmed_authors>Du XJ</pubmed_authors><pubmed_authors>Woodcock EA</pubmed_authors><pubmed_authors>Mu Y</pubmed_authors><pubmed_authors>Chen J</pubmed_authors><pubmed_authors>Cooley N</pubmed_authors><pubmed_authors>Ouyang K</pubmed_authors><pubmed_authors>Kiriazis H</pubmed_authors><pubmed_authors>McMullen JR</pubmed_authors><pubmed_authors>Wu W</pubmed_authors></additional><is_claimable>false</is_claimable><name>No contribution of IP3-R(2) to disease phenotype in models of dilated cardiomyopathy or pressure overload hypertrophy.</name><description>&lt;h4>Background&lt;/h4>We investigated the contribution of inositol(1,4,5)-trisphosphate (Ins(1,4,5)P3 [IP3]) receptors (IP3-R) to disease progression in mouse models of dilated cardiomyopathy (DCM) and pressure overload hypertrophy. Mice expressing mammalian sterile 20-like kinase and dominant-negative phosphatidylinositol-3-kinase in heart (Mst1×dn-PI3K-2Tg; DCM-2Tg) develop severe DCM and conduction block, associated with increased expression of type 2 IP3-R (IP3-R(2)) and heightened generation of Ins(1,4,5)P3. Similar increases in Ins(1,4,5)P3 and IP3-R(2) are caused by transverse aortic constriction.&lt;h4>Methods and results&lt;/h4>To evaluate the contribution of IP3-R(2) to disease progression, the DCM-2Tg mice were further crossed with mice in which the type 2 IP3-R (IP3-R(2)-/-) had been de</description><dates><release>2013-01-01T00:00:00Z</release><publication>2013 Mar</publication><modification>2025-04-19T07:50:51.191Z</modification><creation>2019-03-26T23:49:30Z</creation></dates><accession>S-EPMC4028972</accession><cross_references><pubmed>23258573</pubmed><doi>10.1161/circheartfailure.112.972158</doi><doi>10.1161/CIRCHEARTFAILURE.112.972158</doi></cross_references></HashMap>